Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2447 |  RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 48.72 USD | +1.52% | +2.85% | +3.99% | +61.70% | 910.08 M USD | ||
| 2454 |  ALMS Alumis Inc. - Common Stock | 6.97 USD | +2.95% | -1.97% | -33.30% | +54.55% | 902.16 M USD | ||
| 2459 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 10.58 USD | -1.76% | -9.11% | -28.99% | +10.67% | 900.43 M USD | ||
| 2462 |  JBIO Jade Biosciences, Inc. - Common Stock | 14.15 USD | +2.76% | +2.09% | -27.17% | +40.80% | 899.90 M USD | ||
| 2474 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 10.32 USD | +1.47% | -9.47% | -27.73% | -8.67% | 880.43 M USD | ||
| 2489 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 10.21 USD | -1.92% | -8.10% | -21.82% | +41.02% | 858.87 M USD | ||
| 2513 |  SANA Sana Biotechnology, Inc. - Common Stock | 2.79 USD | +2.57% | -5.42% | -10.00% | -38.00% | 835.22 M USD | ||
| 2519 |  ABUS Arbutus Biopharma Corporation - Common Stock | 4.18 USD | -2.56% | -8.13% | -18.20% | -2.11% | 827.00 M USD | ||
| 2524 |  AVBP ArriVent BioPharma, Inc. - Common Stock | 16.71 USD | -1.07% | -42.89% | -43.05% | -20.73% | 823.93 M USD | ||
| 2532 |  ARDX Ardelyx, Inc. - Common Stock | 3.27 USD | +0.31% | -3.25% | -13.03% | -35.25% | 814.84 M USD | ||
| 2559 |  GERN Geron Corporation - Common Stock | 1.22 USD | +1.67% | +0.83% | -12.86% | -13.48% | 783.82 M USD | ||
| 2562 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 1.76 USD | 0.00% | -4.86% | -16.59% | +6.02% | 783.12 M USD | ||
| 2583 |  ANNX Annexon, Inc. - common stock | 4.00 USD | -0.25% | -4.08% | -5.88% | +22.70% | 758.32 M USD | ||
| 2586 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.76 USD | -3.98% | -4.65% | -5.72% | -18.16% | 753.81 M USD | ||
| 2598 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 7.19 USD | -0.69% | -5.64% | -3.62% | +119.21% | 739.87 M USD | ||
| 2599 |  CADL Candel Therapeutics, Inc. - Common Stock | 9.66 USD | -1.63% | -6.12% | -19.70% | +46.59% | 739.17 M USD | ||
| 2601 |  VSTM Verastem, Inc. - Common Stock | 8.11 USD | -1.93% | +2.01% | +2.53% | -12.51% | 734.47 M USD | ||
| 2605 |  SLDB Solid Biosciences Inc. - Common Stock | 6.82 USD | -0.44% | -6.06% | -30.19% | +19.65% | 731.28 M USD | ||
| 2606 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 11.36 USD | -0.87% | -11.87% | +66.08% | +27.93% | 730.91 M USD | ||
| 2617 |  AVTX Avalo Therapeutics, Inc. - Common Stock | 13.43 USD | -1.10% | -11.41% | -25.06% | -8.76% | 720.25 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |